Research programme: histone deacetylase inhibitors - Sigma-Tau
Alternative Names: ST3595Latest Information Update: 16 Jul 2016
At a glance
- Originator sigma-tau SpA
- Class Hydroxamic acids; Indoles; Small molecules
- Mechanism of Action Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Italy
- 06 Apr 2011 Preclinical trials in Cancer in Italy (unspecified route)
- 16 Apr 2008 Early research in Cancer in Italy (unspecified route)